The sunscreen scandal in Australia continues to escalate. Authorities have already removed 18 products from shelves over safety concerns.
Popular sunscreens fail protection standards
In June, a consumer advocacy group revealed that several leading sunscreens did not provide the protection they promised. Ultra Violette’s Lean Screen Skinscreen claimed SPF 50+ but tested at only SPF 4. The company recalled the product voluntarily in August.
The medicines regulator has since flagged 20 more sunscreens from different brands. All of them used the same base formula, which testing showed to be unreliable.
Investigations reveal low SPF levels
Preliminary testing revealed the formula rarely delivered more than SPF 21. Some products provided as little as SPF 4. Of the 21 products named, eight were recalled or halted. Ten remain suspended, while two are still under review. One product is manufactured in Australia but not sold domestically.
Rising skin cancer rates fuel public concern
Australia has the world’s highest skin cancer rate. Two in three Australians will require at least one cancerous skin removal in their lifetime. Strict sunscreen regulations reflect these risks. The scandal has provoked public outrage and raised international concern. Experts now question both sunscreen production and SPF testing reliability.
Manufacturer stops production of disputed formula
Wild Child Laboratories Pty Ltd, the maker of the base formula, has halted its production. Chief executive Tom Curnow said regulators found no issues at its facility. He argued the discrepancies point to a broader problem across the sunscreen industry.
US testing laboratory faces scrutiny
Regulators have long questioned the reliability of SPF testing. In their latest update, they raised serious concerns about Princeton Consumer Research Corp, a US-based laboratory. Many sunscreen brands relied on this lab to confirm SPF claims.
Mr Curnow confirmed Wild Child has ended ties with the US lab. He said the company now works with accredited independent testers. Regulators contacted all firms linked to the disputed formula or the laboratory. They also wrote to Princeton Consumer Research Corp but have not received a response.
